Today's announcement really shows that Mesoblast is working smartly to address the FDA's legitimate concerns about how Mesoblast would be able to deliver consistent product on a mass production scale. Partnering with Novaris ticks that box and brings us so much closer to the fda giving their approval. Well done SI for working with the system! He's a pro.
Ann: First Quarter Financial Results on Form 6-K, page-10
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.045(4.39%) |
Mkt cap ! $1.127B | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.04 | 97.0¢ | $6.666M | 6.663M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 165562 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 69938 | 23 |
View Market Depth
| Last trade - 14.51pm 24/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |